$QSTG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NURX PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NURX PHARMACEUTICALS, INC.. Get notifications about new insider transactions in NURX PHARMACEUTICALS, INC. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 12 2010 | QSTG | NURX PHARMACEUTICA ... | GERSHICK STEVEN | Chief Financial Of ... | Option Exercise | A | 0.11 | 50,000 | 5,500 | 50,000 | |
Aug 12 2010 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Option Exercise | A | 0.11 | 500,000 | 55,000 | 500,000 | |
Apr 22 2010 | QSTG | NURX PHARMACEUTICA ... | Baradaran Sharyar | Director | Buy | P | 0.00 | 2,777,778 | 0 | 2,777,778 | 0 to 2.8 M |
Apr 22 2010 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Buy | P | 0.00 | 2,777,778 | 0 | 2,777,778 | 0 to 2.8 M |
Mar 01 2010 | QSTG | NURX PHARMACEUTICA ... | LEVINE EVAN | Director | Option Exercise | A | 0.45 | 50,000 | 22,500 | 50,000 | |
Mar 01 2010 | QSTG | NURX PHARMACEUTICA ... | LEVINE EVAN | Director | Gift | G | 0.00 | 11,500 | 0 | 1,130,615 | 1.1 M to 1.1 M (-1.01 %) |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Santa Monica Capital Partners ... | 10% Owner | Gift | G | 0.00 | 50,000 | 0 | 2,387,500 | 2.4 M to 2.4 M (-2.05 %) |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Santa Monica Capital Partners ... | 10% Owner | Sell | S | 0.25 | 400,000 | 100,000 | 2,437,500 | 2.8 M to 2.4 M (-14.10 %) |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Santa Monica Capital Partners ... | 10% Owner | Sell | J | 0.00 | 600,000 | 0 | 2,837,500 | 3.4 M to 2.8 M (-17.45 %) |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Baradaran Sharyar | Director | Option Exercise | A | 4.00 | 768,750 | 3,075,000 | 768,750 | |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Option Exercise | A | 4.00 | 768,750 | 3,075,000 | 768,750 | |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 789,999 | 800 K to 790 K (-1.25 %) |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | LeBel Carl | Director | Option Exercise | D | 4.00 | 50,000 | 200,000 | 0 | |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | LeBel Carl | Director | Option Exercise | A | 0.45 | 50,000 | 22,500 | 50,000 | |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | ROSENTHALE MARVIN E | Director | Option Exercise | D | 4.00 | 50,000 | 200,000 | 0 | |
Feb 24 2010 | QSTG | NURX PHARMACEUTICA ... | ROSENTHALE MARVIN E | Director | Option Exercise | A | 0.45 | 50,000 | 22,500 | 50,000 | |
Feb 01 2010 | QSTG | NURX PHARMACEUTICA ... | GERSHICK STEVEN | Chief Financial Off ... | Gift | G | 0.00 | 50,000 | 0 | 52,500 | 2.5 K to 52.5 K (+2,000.00 %) |
Nov 12 2009 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Chief Executive Off ... | Option Exercise | A | 0.45 | 500,000 | 225,000 | 500,000 | |
Nov 04 2009 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Director | Option Exercise | P | 4.00 | 153,000 | 612,000 | 153,000 | |
Nov 04 2009 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Director | Buy | P | 0.25 | 200,000 | 50,000 | 799,999 | 600 K to 800 K (+33.33 %) |
Nov 04 2009 | QSTG | NURX PHARMACEUTICA ... | Padma-Nathan Harin | Director | Buy | P | 0.00 | 99,999 | 0 | 599,999 | 500 K to 600 K (+20.00 %) |
Nov 04 2009 | QSTG | NURX PHARMACEUTICA ... | Baradaran Sharyar | Director | Option Exercise | P | 4.00 | 1,383,750 | 5,535,000 | 1,383,750 | |
Nov 04 2009 | QSTG | NURX PHARMACEUTICA ... | Baradaran Sharyar | Director | Buy | P | 0.25 | 200,000 | 50,000 | 1,225,000 | 1 M to 1.2 M (+19.51 %) |
Nov 04 2009 | QSTG | NURX PHARMACEUTICA ... | Baradaran Sharyar | Director | Buy | P | 0.00 | 900,000 | 0 | 1,025,000 | 125 K to 1 M (+720.00 %) |
Sep 30 2009 | QSTG | NURX PHARMACEUTICA ... | Hunter World Markets, Inc. | 10% Owner | Option Exercise | S | 4.00 | 1,537,500 | 6,150,000 | 1,537,500 | |
Sep 30 2009 | QSTG | NURX PHARMACEUTICA ... | Hunter World Markets, Inc. | 10% Owner | Buy | S | 0.20 | 999,999 | 200,000 | 209,442 | -790,557 to 209.4 K (-126.49 %) |
May 27 2009 | QSTG | NURX PHARMACEUTICA ... | Hunter World Markets, Inc. | 10% Owner | Sell | S | 0.22 | 1,090,558 | 239,923 | 1,209,442 | 2.3 M to 1.2 M (-47.42 %) |
Mar 10 2009 | QSTG | NURX PHARMACEUTICA ... | GERSHICK STEVEN | Chief Financial Off ... | Option Exercise | A | 0.45 | 250,000 | 112,500 | 250,000 | |
Feb 12 2009 | QSTG | NURX PHARMACEUTICA ... | GERSHICK STEVEN | Chief Financial Off ... | Gift | G | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Feb 12 2009 | QSTG | NURX PHARMACEUTICA ... | Brendlinger Kurt | Director | Gift | G | 0.00 | 54,625 | 0 | 145,375 | 200 K to 145.4 K (-27.31 %) |
May 19 2008 | QSTG | NURX PHARMACEUTICA ... | GERSHICK STEVEN | Chief Financial Off ... | Option Exercise | A | 4.00 | 75,000 | 300,000 | 75,000 | |
Mar 28 2008 | QSTG | NURX PHARMACEUTICA ... | Baradaran Sharyar | Director | Buy | P | 0.55 | 95,000 | 52,250 | 595,000 | 500 K to 595 K (+19.00 %) |
Sep 05 2007 | QSTG | NURX PHARMACEUTICA ... | Hunter World Markets, Inc. | 10% Owner | Sell | S | 0.75 | 2,500,000 | 1,875,000 | 9,500,000 | 12 M to 9.5 M (-20.83 %) |
May 15 2007 | QSTG | NURX PHARMACEUTICA ... | BATEMAN DYNASTY, LC | Sell | D | 0.13 | 4,143,000 | 538,590 | 1,230,000 | 5.4 M to 1.2 M (-77.11 %) | |
Oct 24 2006 | QSTG | NURX PHARMACEUTICA ... | Davis Craig Alan | CEO | Sell | S | 0.02 | 1,615,000 | 32,300 | 1,025,000 | 2.6 M to 1 M (-61.17 %) |
Page: 1